Newman Dignan & Sheerar Inc’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.75M Sell
7,582
-43
-0.6% -$14.7K 0.53% 48
2026
Q1
$2.68M Sell
7,625
-198
-3% -$70.6K 0.56% 43
2025
Q4
$2.56M Buy
7,823
+176
+2% +$55.8K 0.53% 46
2025
Q3
$2.16M Sell
7,647
-408
-5% -$118K 0.47% 53
2025
Q2
$2.25M Sell
8,055
-30
-0.4% -$8.5K 0.52% 49
2025
Q1
$2.52M Buy
8,085
+81
+1% +$23.9K 0.69% 40
2024
Q4
$2.09M Sell
8,004
-159
-2% -$47.2K 0.53% 49
2024
Q3
$2.59M Sell
8,163
-30
-0.4% -$9.81K 0.62% 45
2024
Q2
$2.56M Sell
8,193
-689
-8% -$202K 0.66% 41
2024
Q1
$2.53M Sell
8,882
-513
-5% -$150K 0.68% 41
2023
Q4
$2.71M Sell
9,395
-79
-0.8% -$21.5K 0.82% 37
2023
Q3
$2.55M Sell
9,474
-267
-3% -$66.6K 0.84% 37
2023
Q2
$2.16M Sell
9,741
-57
-0.6% -$13.2K 0.67% 43
2023
Q1
$2.37M Sell
9,798
-151
-2% -$37.1K 0.76% 37
2022
Q4
$2.61M Buy
9,949
+2
+0% +$536 0.87% 37
2022
Q3
$2.24K Sell
9,947
-35
-0.4% -$8.48K 0.35% 37
2022
Q2
$2.43M Buy
9,982
+69
+0.7% +$16.9K 0.83% 35
2022
Q1
$2.4K Buy
9,913
+12
+0.1% +$2.76K 0.46% 39
2021
Q4
$2.23M Sell
9,901
-66
-0.7% -$13.9K 0.68% 41
2021
Q3
$2.12M Buy
9,967
+1
+0% +$230 0.61% 38
2021
Q2
$2.43M Sell
9,966
-119
-1% -$29.3K 0.82% 31
2021
Q1
$2.51M Sell
10,085
-535
-5% -$128K 0.91% 32
2020
Q4
$2.44K Sell
10,620
-98
-0.9% -$22.6K 0.39% 33
2020
Q3
$2.72M Sell
10,718
-19
-0.2% -$4.71K 1.14% 23
2020
Q2
$2.64M Buy
10,737
+135
+1% +$30.8K 1.14% 24
2020
Q1
$2.35M Sell
10,602
-108
-1% -$23.6K 1.23% 20
2019
Q4
$2.58K Sell
10,710
-86
-0.8% -$19K 0.28% 27
2019
Q3
$2.09M Buy
10,796
+80
+0.7% +$15.4K 0.98% 28
2019
Q2
$1.98K Sell
10,716
-265
-2% -$47.5K 0.05% 28
2019
Q1
$2.09M Sell
10,981
-247
-2% -$47.2K 0.84% 29
2018
Q4
$2.19K Buy
11,228
+510
+5% +$99.5K 0.19% 31
2018
Q3
$2.19M Buy
10,718
+136
+1% +$26.8K 0.96% 28
2018
Q2
$1.95K Buy
10,582
+212
+2% +$37.5K 0.13% 27
2018
Q1
$1.78M Sell
10,370
-601
-5% -$110K 0.9% 28
2017
Q4
$1.91M Sell
10,971
-115
-1% -$20.4K 0.95% 27
2017
Q3
$2.07M Sell
11,086
-149
-1% -$26.4K 1.1% 24
2017
Q2
$1.94M Buy
11,235
+185
+2% +$30.1K 1.07% 24
2017
Q1
$1.81K Sell
11,050
-5
-0% -$831 0.8% 31
2016
Q4
$1.62M Sell
11,055
-175
-2% -$26.3K 0.99% 29
2016
Q3
$1.87M Buy
11,230
+201
+2% +$34K 1.18% 23
2016
Q2
$1.68M Buy
11,029
+195
+2% +$30.3K 1.05% 26
2016
Q1
$1.62M Buy
10,834
+156
+1% +$23.2K 1.18% 23
2015
Q4
$1.73M Buy
10,678
+83
+0.8% +$13K 1.22% 24
2015
Q3
$1.47M Buy
10,595
+51
+0.5% +$8.04K 0.94% 25
2015
Q2
$1.62M Sell
10,544
-93,453
-90% -$15M 1.17% 23
2015
Q1
$1.66M Buy
103,997
+93,618
+902% +$14.7M 1.19% 21
2014
Q4
$1.65K Sell
10,379
-93,403
-90% -$14.6M 0.99% 26
2014
Q3
$1.46M Buy
103,782
+93,374
+897% +$12.2M 1.1% 25
2014
Q2
$1.23K Buy
10,408
+1,200
+13% +$139K 0.7% 38
2014
Q1
$1.14M Buy
9,208
+2,678
+41% +$325K 0.81% 39
2013
Q4
$745 Buy
6,530
+2,395
+58% +$272K 0.04% 63
2013
Q3
$463K Buy
4,135
+403
+11% +$43.7K 0.36% 87
2013
Q2
$368 Buy
+3,732
New +$387K 0.03% 94

Other funds holding AMGN

Newman Dignan & Sheerar Inc's AMGN Position: Q2 2026 in Review

Newman Dignan & Sheerar Inc reduced its Amgen (AMGN) stake by 0.56% in Q2 2026, selling an estimated $14.7K and leaving 7,582 shares worth $2.75M. The position accounts for 0.53% of the portfolio, ranked #48.

Newman Dignan & Sheerar Inc first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Newman Dignan & Sheerar Inc held 7,582 shares of Amgen worth $2.75M as of Q2 2026.
  • Newman Dignan & Sheerar Inc sold 43 Amgen shares in Q2 2026, an estimated $14.7K.
  • Amgen made up 0.53% of Newman Dignan & Sheerar Inc's portfolio in Q2 2026, its #48 holding.
  • Newman Dignan & Sheerar Inc first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q2 2026, filed 14 Jul 2026.